Cancer Research UK Cancer Centre, School of Cancer Sciences, University of Birmingham, Vincent Drive, Edgbaston, Birmingham B15 2TT, UK.
Mol Cancer. 2010 Jun 18;9:155. doi: 10.1186/1476-4598-9-155.
Epstein-Barr virus (EBV)-encoded LMP1 protein is commonly expressed in nasopharyngeal carcinoma (NPC). LMP1 is a prime candidate for driving tumourigenesis given its ability to activate multiple signalling pathways and to alter the expression and activity of variety of downstream targets. Resistance to TGFbeta-mediated cytostasis is one of the growth transforming effects of LMP1. Of the downstream targets manipulated by LMP1, the induction of Id1 and inactivation of Foxo3a appear particularly relevant to LMP1-mediated effects. Id1, a HLH protein is implicated in cell transformation and plays a role in cell proliferation, whilst Foxo3a, a transcription factor controls cell integrity and homeostasis by regulating apoptosis. The mechanism(s) by which LMP1 induces these effects have not been fully characterised.
In this study, we demonstrate that the ability of LMP1 to induce the phosphorylation and inactivation of Foxo3a is linked to the upregulation of Id1. Furthermore, we show that the induction of Id1 is essential for the transforming function of LMP1 as over-expression of Id1 increases cell proliferation, attenuates TGFbeta-SMAD-mediated transcription and renders cells refractory to TGFbeta-mediated cytostasis. Id1 silencing in LMP1-expressing epithelial cells abolishes the inhibitory effect of LMP1 on TGFbeta-mediated cell growth arrest and reduces the ability of LMP1 to attenuate SMAD transcriptional activity. In response to TGFbeta stimulation, LMP1 does not abolish SMAD phosphorylation but inhibits p21 protein expression. In addition, we found the induction of Id1 in LMP1-expressing cells upon stimulation by TGFbeta. We provide evidence that LMP1 suppresses the transcriptional repressor ATF3, possibly leading to the TGFbeta-induced Id1 upregulation.
The current data provide novel information regarding the mechanisms by which LMP1 suppresses TGFbeta-induced cytostasis, highlighting the importance of Id1 in LMP1 mediated cell transformation.
Epstein-Barr 病毒(EBV)编码的 LMP1 蛋白在鼻咽癌(NPC)中普遍表达。由于其能够激活多种信号通路并改变多种下游靶标的表达和活性,LMP1 是驱动肿瘤发生的主要候选物。对 TGFβ介导的细胞静止的抵抗是 LMP1 的生长转化作用之一。在 LMP1 调控的下游靶标中,Id1 的诱导和 Foxo3a 的失活似乎与 LMP1 介导的效应特别相关。Id1 是一种 HLH 蛋白,参与细胞转化,在细胞增殖中发挥作用,而转录因子 Foxo3a 通过调节细胞凋亡来控制细胞完整性和动态平衡。LMP1 诱导这些效应的机制尚未完全阐明。
在这项研究中,我们证明了 LMP1 诱导 Foxo3a 磷酸化和失活的能力与 Id1 的上调有关。此外,我们表明,Id1 的诱导对于 LMP1 的转化功能是必不可少的,因为 Id1 的过表达增加了细胞增殖,减弱了 TGFβ-SMAD 介导的转录,并使细胞对 TGFβ 介导的细胞静止产生抗性。在表达 LMP1 的上皮细胞中沉默 Id1 会消除 LMP1 对 TGFβ 介导的细胞生长抑制的抑制作用,并降低 LMP1 减弱 SMAD 转录活性的能力。在 TGFβ 刺激下,LMP1 不会消除 SMAD 磷酸化,但会抑制 p21 蛋白表达。此外,我们发现 TGFβ 刺激表达 LMP1 的细胞会诱导 Id1 的表达。我们提供的证据表明,LMP1 抑制转录抑制因子 ATF3,可能导致 TGFβ 诱导的 Id1 上调。
目前的数据提供了有关 LMP1 抑制 TGFβ 诱导细胞静止的机制的新信息,突出了 Id1 在 LMP1 介导的细胞转化中的重要性。